Publications | Lund University Publications

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Tilly%2C+Herv%C3%A9%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Tilly%2C+Herv%C3%A9%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2021
Mark EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma : Recommendations for the Second Phase of the COVID-19 Pandemic
Dreyling, Martin ; Aurer, Igor ; Federico, Massimo ; Jerkeman, Mats ^LU ; Kersten, Marie Jose ; Linton, Kim ; Mey, Ulrich ; Tilly, Herve and Buske, Christian (2021) In HemaSphere 5(2). p.529-529
- Contribution to journal › Scientific review
2016
Mark The european hematology association roadmap for european hematology research : A consensus document
Engert, Andreas ; Balduini, Carlo ; Brand, Anneke ; Coiffier, Bertrand ; Cordonnier, Catherine ; Döhner, Hartmut ; De Wit, Thom Duyvené ; Eichinger, Sabine ; Fibbe, Willem and Green, Tony , et al. (2016) In Haematologica 101(2). p.115-208
- Contribution to journal › Article
2010
Mark Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma
d'Amore, Francesco ; Radford, John ; Relander, Thomas ^LU ; Jerkeman, Mats ^LU ; Tilly, Herve ; Osterborg, Anders ; Morschhauser, Franck ; Gramatzki, Martin ; Dreyling, Martin and Bang, Bo , et al. (2010) In British Journal of Haematology 150(5). p.565-573
- Contribution to journal › Article

your query:: Remove author: Tilly, Hervé